Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
pan-HPV type vaccine
- Development stage
- Preclinical
- Lead developer
- Xiamen Innovax Biotech
- Administration
- Intramuscular
01
Overview
The pan-HPV type vaccine is a preclinical recombinant protein vaccine candidate developed by Xiamen YangShengTang Biotechnic. Utilizing an E. coli-based virus-like particle (VLP) platform, the vaccine is designed to provide universal protection against all human papillomavirus (HPV) types. It is primarily being developed for the prevention of HPV infection and cervical cancer, aiming to surpass the coverage of existing multivalent vaccines by targeting the full spectrum of HPV genotypes.
- Other names
- 所有HPV型别疫苗all-HPV-types vaccine
02
Targets
Human papillomavirus type 45 L1 capsid protein (HPV45 L1)Human papillomavirus type 31 L1 capsid proteinHuman papillomavirus type 16 major capsid protein L1HPV33 L1HPV52 L1 (Human papillomavirus type 52 major capsid protein L1)HPV6 L1 (Human papillomavirus type 6 major capsid protein L1)HPV58 L1 (Human papillomavirus type 58 major capsid protein L1)Human papillomavirus type 18 L1 capsid protein (HPV18 L1)HPV11 L1
Beyond the preview
Go deeper on pan-HPV type vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on pan-HPV type vaccine.